Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT07291193
Eligibility Criteria:
Inclusion Criteria:
* Common criteria :
* Subject\>18 years and \<45 years,
* Written informed consent of the subject,
* Subject affiliated to the Assurance Maladie (French Health System) except Aide Médicale d'Etat (French State Medical Aid),
* Subject agrees that genomic analyses may be carried out on the samples
* Specific criteria :
* For pregnant women:Third trimester of pregnancy (between 29-37 weeks of amenorrhea).
* For HS subjects: Subject with hidradenitis suppurativa lesions at the sampling sites.
Exclusion Criteria:
* Common criteria :
* Subject immunocompromised,
* Subject under legal protection (guardianship or curatorship),
* Subject is unable to provide informed consent and to comply with the study requirements due to geographical, social, or psychiatric reasons,
* Subject in other research whose procedures may influence the immune system,
* Contraindication to any of medications listed in section 5.1 (antiseptic and local anesthetic used for biopsy(ies)),
* Subject whose health condition does not permit participation in study procedures.
* Specific criteria :
* For no HS subjects : Scarred skin at the biopsy site, Subject with pre-existing and/or still active inflammatory skin conditions, Subject experiencing early menopause (women) or andropause (men).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT07291193
Study Brief:
Protocol Section:
NCT07291193